In regard to the current situation due to the COVID-19 epidemic and after careful consideration, the organization committee (Bioaster, Lyonbiopôle and MabDesign), with the approval of scientific advisory committee, has decided to digitize the fourth edition of the Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2020), that will be held on December 9-10, 2020
Rest assured that this new format will in no way impede the quality of the I4ID2020 Congress.
The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.
I4ID2020 will build on the successes of the first three editions, I4ID2017, I4ID2018 & I4ID2019 that counted with the presence of more than 550 participants from different countries representing over 300 organizations and 100 internationally renowned speakers exchanging on immunotherapy and new therapeutic approaches to fight infectious diseases.
The I4ID2020 edition will largely address the current COVID-19 pandemics as well as other infectious diseases. The Scientific Committee has set-up a stimulating program focusing on Detection, Diagnosis, Clinical Trials immunotherapies and Innovative therapeutic approaches to prevent & fight infectious diseases.
The I4ID2020 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.
Moreover, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering, through an online B2B platform.
Are you interested in attending the Immunotherapies & Innovations for Infectious Diseases – I4ID Congress? Come to check out our program.
Do you want your company to be visible at the I4ID2020 conference? Check out our sponsors & exhibitors’ opportunities.
Looking forward to welcoming you in December 9-10, 2020 in virtual format.
The Organizing Committee – BIOASTER, Lyonbiopole and MabDesign
The Scientific Committee